PLS chart, page-5333

I would never pretend to be a chartist.
However, even the most juvenile examination of a chart
clearly indicates how out of sync the price movement of
the stock since the middle of December is with the price
movement of spodumeme. I have never seen anything quite
like this over such an extended period of time.

Sooner or later, when the forces who are making this divergence
occur stop, some semblence of order will return. In the meantime
our cash position and profits continue to grow dramatically.
This is not advice, but it sure does look like a reasonable buying
opportunity.